EPT

This page has not been approved by the PsychonautWiki administrators. It may potentially contain incorrect information, particularly regarding that of dosage, duration, subjective effects, toxicity and other risks.

Summary sheet: EPT

EPT
Molecular structure of EPT
Chemical Nomenclature
Common names	EPT
Substitutive name	N-Ethyl-N-propyltryptamine
Systematic name	3-[2-(Ethyl(propyl)amino)ethyl]-1H-indole
Class Membership
Psychoactive class	Psychedelic
Chemical class	Tryptamine
Routes of Administration
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section. Insufflated Dosage Light 20 - 40 mg Common 40 - 80 mg Strong 80 - 110 mg Heavy 110 mg + Duration Total 2 - 4 hours Onset 5 - 20 minutes After effects 1 - 3 hours DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

N-Ethyl-N-propyltryptamine (also known as EPT) is a lesser-known novel psychedelic substance of the tryptamine class that produces psychedelic effects when administered. It is structurally related to tryptamines like DMT, MET, DET, and DPT.

Early reports have described the effects of EPT as mild and indistinct compared to structurally similar base tryptamines such as DMT, DET and DPT, all of which are highly powerful psychedelics. Of these, it is reported to be most similar to DPT, albeit less potent and with a less immersive headspace.

Very little data exists about the pharmacological properties, metabolism, and toxicity of EPT, and it has no history of human use before 2016. It is highly advised to use harm reduction practices if using this substance.

Chemistry

This chemistry section is incomplete. You can help by adding to it.

EPT, or N-ethyl-N-propyltryptamine, is a synthetic indole molecule of the tryptamine chemical class. Tryptamines share a core structure comprised of a bicyclic indole heterocycle attached at R₃ to an amino group via an ethyl side chain. EPT features one propyl and one ethyl groups bound to the terminal amine R_N of its tryptamine backbone.

EPT is the ethyl analog of DPT and the propyl analog of DET.

Pharmacology

Further information: Serotonergic psychedelic

Like with most psychedelic tryptamines, EPT is thought to act principally as a 5-HT_2A partial agonist. The psychedelic effects are believed to come from EPT's binding efficacy at the 5-HT_2A receptors.

However, the role of these interactions and how they result in the psychedelic experience remain the subject of ongoing scientific investigation.

Subjective effects

This subjective effect breakdown is a stub. As such, it may contain incomplete or wrong information and is still in progress. You can help by expanding it.

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects should be taken with a grain of salt and will rarely (if ever) occur all at once, but heavier doses will increase the chances and are more likely to induce a full range of effects. Likewise, adverse effects become much more likely on higher doses and may include serious injury or death. The effects of EPT have not been researched as well as many other tryptamines. The following effects are drawn from a relatively limited sample size.

Physical effects

• • Stimulation
  • Increased libido
  • Motor control loss
  • Nausea
  • Pupil dilation
  • Perception of bodily lightness

Visual effects

• Enhancements

  • Colour enhancement
  • Pattern recognition enhancement

  Distortions

  • Diffraction
  • Drifting (melting, breathing, morphing and flowing)
  • Object alterations
  • Symmetrical texture repetition

  Geometry

  Hallucinatory states

  • Internal hallucinations

Cognitive effects

• • Memory suppression
  • Personal bias suppression
  • Thought acceleration
  • Time distortion

Auditory effects

• • Auditory distortion
  • Auditory enhancement

Experience reports

Anecdotal reports which describe the effects of this compound within our experience index include:

• Experience: 80mg EPT - Bummer
• Experience: 80mg EPT - Slight improvement

Additional experience reports can be found here:

• Erowid Experience Vaults: EPT

Toxicity and harm potential

Further information: Research chemicals § Toxicity and harm potential, and Responsible use § Hallucinogens

The toxicity and long-term health effects of recreational EPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because EPT is a research chemical with a very limited history of human usage.

Anecdotal evidence from people within the community who have tried EPT suggests that there are no negative health effects attributed to simply trying it by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.

It is strongly recommended that one use harm reduction practices when using this substance.

Tolerance and addiction potential

EPT is not habit-forming and the desire to use it can actually decrease with regular consumption. Like with most psychedelics, it is most often thought to be self-regulating.

Tolerance to the effects of EPT are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). EPT presents cross-tolerance with all psychedelics, meaning that after the consumption of EPT all psychedelics will have a reduced effect.

Legal status

This legality section is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it.

Due to its relative obscurity, the possession and sale of EPT is unscheduled in most countries.

• United Kingdom: EPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.
• United States: EPT is unscheduled in the United States. It may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.

See also

• Responsible use
• Research chemical
• Psychedelic
• Tryptamine
• DPT
• 4-AcO-EPT
• 4-HO-EPT

External links

• EPT (Isomer Design)